Charlotte's Web (CWBHF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
The annual general and special meeting will be held virtually on May 28, 2026, with shareholders voting on key proposals including director elections, auditor appointment, and a significant transaction involving BT DE Investments Inc. (BAT), a subsidiary of British American Tobacco.
The proxy materials, including the annual report and benefit report, are distributed via notice-and-access to reduce costs and environmental impact.
The company is an emerging growth company and utilizes scaled disclosure and exemptions under the JOBS Act until at least December 31, 2027.
Voting matters and shareholder proposals
Shareholders will vote to set the number of directors at six, elect six directors, appoint PKF O'Connor Davies LLP as auditors, and approve the amendment and conversion of a C$75.3 million convertible debenture held by BAT, which could result in BAT becoming a control person with over 40% ownership.
The board recommends voting FOR all proposals.
Shareholder proposals for the next annual meeting must be submitted by December 31, 2026, and director nominations must comply with advance notice and universal proxy rules.
Board of directors and corporate governance
The board consists of six directors, with three considered independent under Nasdaq and Canadian rules.
Committees include Audit, Compensation, and Corporate Governance and Nominating, each with independent chairs.
The board has adopted a written mandate, code of ethics, and policies for director qualifications, diversity, and share ownership.
No term limits or mandatory retirement ages for directors; 50% of the board and executive officers are women.
Latest events from Charlotte's Web
- Q2 2026 saw revenue drop, margin expand, and a major equity conversion strengthen the balance sheet.CWBHF
Q2 2026 - Market-leading CBD innovator, recapitalized for growth and positioned for regulatory-driven expansion.CWBHF
Investor presentation - All resolutions passed, with BAT gaining 40% ownership and a Medicare pilot seen as a major growth driver.CWBHF
AGM 2026 - Q1 2026 revenue dropped 9% and net loss widened, with a major BAT debt deal pending approval.CWBHF
Q1 2026 - Returned to growth as the #1 CBD brand, leveraging innovation, partnerships, and regulatory momentum.CWBHF
Investor presentation - Shareholders to vote on BAT transaction, director elections, and key governance matters.CWBHF
Proxy filing - Key votes include director elections and a debenture amendment that may shift company control.CWBHF
Proxy filing - Transformed balance sheet, renewed growth, and Medicare pilot position drive future upside.CWBHF
Q4 2025 - Sequential revenue growth and cost cuts signal a turnaround amid regulatory challenges.CWBHF
Q2 2024